Short Interest in Phibro Animal Health Co. (NASDAQ:PAHC) Drops By 17.5%

Phibro Animal Health Co. (NASDAQ:PAHC) was the recipient of a large decrease in short interest in March. As of March 31st, there was short interest totalling 706,200 shares, a decrease of 17.5% from the March 15th total of 855,800 shares. Approximately 3.5% of the shares of the company are short sold. Based on an average trading volume of 145,000 shares, the short-interest ratio is currently 4.9 days.

Phibro Animal Health Trading Up 0.2 %

Shares of PAHC opened at $13.11 on Monday. Phibro Animal Health has a 1 year low of $9.40 and a 1 year high of $15.98. The company has a current ratio of 3.12, a quick ratio of 1.60 and a debt-to-equity ratio of 1.66. The stock has a 50 day simple moving average of $12.54 and a 200-day simple moving average of $11.73. The stock has a market cap of $530.96 million, a PE ratio of 36.42, a PEG ratio of 4.85 and a beta of 0.75.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.06. The business had revenue of $249.90 million during the quarter, compared to analysts’ expectations of $242.91 million. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. On average, sell-side analysts predict that Phibro Animal Health will post 1.12 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Wednesday, March 6th were given a dividend of $0.12 per share. The ex-dividend date was Tuesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 3.66%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 133.33%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. China Universal Asset Management Co. Ltd. lifted its stake in shares of Phibro Animal Health by 358.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock valued at $27,000 after purchasing an additional 1,843 shares during the period. Rockefeller Capital Management L.P. lifted its stake in shares of Phibro Animal Health by 24,840.0% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,494 shares of the company’s stock valued at $32,000 after purchasing an additional 2,484 shares during the period. PNC Financial Services Group Inc. lifted its stake in shares of Phibro Animal Health by 92.1% in the 4th quarter. PNC Financial Services Group Inc. now owns 2,478 shares of the company’s stock valued at $33,000 after purchasing an additional 1,188 shares during the period. FMR LLC lifted its stake in shares of Phibro Animal Health by 207.8% in the 1st quarter. FMR LLC now owns 2,158 shares of the company’s stock valued at $33,000 after purchasing an additional 1,457 shares during the period. Finally, Qube Research & Technologies Ltd acquired a new position in shares of Phibro Animal Health in the 3rd quarter valued at $34,000. 99.34% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Tuesday, April 9th.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.